Description
LY2090314 is an inhibitor of glycogen synthase kinase (GSK-3).
Product Unit Size | Cost | Quantity | Stock |
---|
LY2090314 is an inhibitor of glycogen synthase kinase (GSK-3).
Cas No. | 603288-22-8 |
---|---|
Purity | ≥98% |
Formula | C28H25FN6O3 |
Formula Wt. | 512.53 |
IUPAC Name | 3-[6-fluoro-10-(piperidine-1-carbonyl)-1,10-diazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-3-yl]-4-imidazo[1,2-a]pyridin-3-ylpyrrole-2,5-dione |
Synonym | LY2090314 |
Solubility | DMSO 100 mg/mL (195.11 mM) Ethanol 2 mg/mL warmed (3.9 mM) Water Insoluble |
Appearance | Yellow Powder |
Store Temp | 4°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Zamek-Gliszczynski MJ, Abraham TL, Alberts JJ, et al. Pharmacokinetics, metabolism, and excretion of the glycogen synthase kinase-3 inhibitor LY2090314 in rats, dogs, and humans: a case study in rapid clearance by extensive metabolism with low circulating metabolite exposure. Drug Metab Dispos. 2013 Apr;41(4):714-26. PMID: 23305709.
Coumarin; VKORC1 inhibitor.
Regioisomers
NSAID; COX-1/2 and PDE inhibitor.
Imidazole; 14-α demethylase inhibitor, potenti...
EphB4 inhibitor.
Endogenous opioid peptide; δOR and μOR agonis...
Glycylcycline; protein synthesis inhibitor.
NSAID; COX-1/2 and PDE inhibitor.
Synthetic steroid hormone; ER agonist.
Polyketide; CRM1 inhibitor.
Synthetic cafestol derivative.
MAO-A/B inhibitor.
Found in Capsicum; TRPV agonist.
Protein translocation inhibitor.
Benzimidazole; microtubule polymerization inhib...
Selective inhibitor of PI3Kβ and PI3Kδ.
ACE inhibitor.
Sesquiterpene lactone derived from Artemesia; m...
Found in Piper longum.
Mycotoxin produced by Penicillum, Aspergillus, ...